Tag: multiplex assays market demand

  • What’s Driving Growth in the Multiplex Assays Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Multiplex Assays Market? Insights into Key Trends and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the multiplex assays market?

    The market size for multiplex assays has significantly expanded in past years. This market is projected to increase from a worth of $3.67 billion in 2024 to $3.92 billion in 2025, registering a compound annual growth rate (CAGR) of 6.9%. Factors such as a surge in healthcare spending, growth of emerging markets, fast-paced technological advancements, and a swift increase in the elderly populace have contributed to the historical growth of this market.

    What will be the multiplex assays market size in the future?

    The market size of lab supplies is projected to witness significant expansion in the upcoming years, potentially reaching $57.2 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to such growth over the forecast period include an increase in life sciences research, enhanced emphasis on environmental tests, augmented importance of point-of-care testing, global actions towards health crises, and progress in genomic medicine. The future trends mainly revolve around the adoption of biodegradable materials, strict quality and safety regulations, partnerships with research bodies, global supply chain improvements, and adoption of single-use technologies.

    Get your multiplex assays market report here!

    https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

    What main drivers are fueling expansion in the multiplex assays market?

    The surge in chronic illness occurrences is fueling the expansion of the worldwide multiplex assay market. This multiplex assay is widely utilized in clinical trials to evaluate and investigate the potency of a disease, and to identify antibodies against these diseases. As an illustration, in September 2023, a report from the World Health Organization, a global health organization based in Switzerland, highlighted that chronic diseases, also referred to as non-communicable diseases (NCDs), contributed to 74% of total global deaths, equal to 41 million fatalities. Consequently, the escalating prevalence of chronic illnesses is propelling the growth of the global multiplex assay market.

    What key areas define the segmentation of the global multiplex assays market?

    The multiplex assays market covered in this report is segmented –

    1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

    2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

    3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

    4) By Application: Research And Development, Clinical Diagnostics

    5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

    Subsegments:

    1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays

    2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR)

    3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

    Who are the dominant players expanding their reach in the multiplex assays market?

    Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

    How are evolving market trends shaping multiplex assays Strategies?

    In an effort to consolidate their market position, businesses in the industry are introducing creative tests grounded on multiplex assays. For example, in May 2022, QuantuMDx Group Limited, a UK firm that specializes in transformative point-of-care diagnostics, unveiled its latest respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay. This multiplex panel, dubbed the Q-POCTM SARS-CoV-2, Flu A/B, and RSV Assay, is able to identify SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) as needed.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5775

    Which regions are emerging as leaders in the multiplex assays market?

    North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Neurophysiology Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

    Neuroprosthetics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

    Neurostimulation Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Multiplex Assays Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Multiplex Assays Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted CAGR for the Multiplex Assays Market Over the Forecast Period of 2025 to 2034?

    In the past few years, the size of the multiplex assays market has experienced significant growth. The market, estimated to be worth $3.67 billion in 2024, is projected to increase to $3.92 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%. Factors contributing to the growth during the historic period include an increase in healthcare spending, expansion in emerging markets, swift advancements in technology, and a substantial rise in the senior population.

    The market size for multiplex assays is projected to witness robust growth in the coming years, with an estimate of reaching $5.42 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 8.4%. This growth trajectory during the forecasted period is lined up with factors such as increased funding, governmental efforts towards genetic and microbiological studies, an aging populace, a surge in chronic diseases, and swift escalation in assorted bacterial and viral outbreaks. The key trendsetters for the forecast period are the stepping up of funding, government-led initiatives pushing genetic and microbiological research, expansion of the elderly population, spiraling cases of chronic health conditions and the fast-paced rise in various bacterial and viral epidemics.

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the multiplex assays Market?

    The upsurge in chronic disease rates is fueling the expansion of the worldwide multiplex assay market. This assay is largely employed in clinical research to investigate and confirm the effectiveness of a disease and to detect antibodies against such diseases. For example, a World Health Organization report released in September 2023 indicated that chronic diseases, also referred to as non-communicable diseases (NCDs), account for 74% of global deaths, amounting to 41 million fatalities. Hence, the escalating prevalence of chronic illnesses is propelling the global multiplex assay market.

    Request Your Free Multiplex Assays Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

    Who Are the Top Companies Driving Innovation and Growth in the Multiplex Assays Market?

    Major companies operating in the multiplex assays market include:

    • Seegene Inc_x000D_

    • DiaSorin SpA_x000D_

    • Thermo Fisher Scientific Inc_x000D_

    • Bio-Rad Laboratories Inc_x000D_

    • Abcam Plc_x000D_

    What Key Trends Are Currently Impacting the Multiplex Assays Market’s Development?

    Firms within the market are introducing innovative examinations using multiplex assays as a strategy to solidify their market presence. For example, in May 2022, QuantuMDx Group Limited, a UK-based point-of-care diagnostics innovator, unveiled its new Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay. This multiplex panel respiratory test by Q-POCTM is capable of detecting SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) at the point of demand.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

    What Are the Major Categories and Their Growth Dynamics in the Multiplex Assays Market?

    The multiplex assays market covered in this report is segmented –

    1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

    2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

    3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

    4) By Application: Research And Development, Clinical Diagnostics

    5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

    Subsegments:

    1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays

    2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR)

    3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

    Which Geographical Regions Are Pioneering Growth in the Multiplex Assays Market?

    North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Defining Aspects of the Multiplex Assays Market Landscape?

    Multiplex assays are used to amplify multiple targets in a polymerase chain response (PCR) trial and collect further information from nanosecond amounts of proteins or other analyses in lower time as compared to the conventional system, similar to ELISA. Multiplex assays are used for pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and others.

    Browse Through More Similar Reports By The Business Research Company:

    Neurophysiology Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

    Neuroprosthetics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

    Neurostimulation Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Takeaways From The Global Multiplex Assay Market Forecast 2024

    Key Takeaways From The Global Multiplex Assay Market Forecast 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Multiplex Assay Global Market Report 2024, the multiplex assay market is expected to show significant growth in the forecast period.

    Introduction

    The multiplex assays market has experienced robust growth in recent years, with its size increasing from $3.61 billion in 2023 to $3.96 billion in 2024, at a compound annual growth rate (CAGR) of 9.7%. This blog explores the factors driving this growth and what we can expect in the future.

    • Rapid growth from $3.61 billion in 2023 to $3.96 billion in 2024.
    • 9.7% CAGR driven by various market factors.

    Historical Growth Factors

    Increased Healthcare Expenditure

    • More spending on healthcare globally.
    • Investment in advanced diagnostic technologies.

    Growth in Emerging Markets

    • Expanding healthcare infrastructure.
    • Increased adoption of multiplex assays.

    Rapid Technological Advances

    • Innovations in assay technologies.
    • Improved accuracy and efficiency.

    Aging Population

    • More older adults needing medical care.
    • Increased prevalence of age-related diseases.

    Future Growth Projections

    Rising Market Size

    • Expected to grow to $5.7 billion by 2028.
    • Sustained CAGR of 9.5% from 2024 to 2028.

    Key Growth Drivers

    • Increased funding and government initiatives for research.
    • Aging population and prevalence of chronic diseases.
    • Rise in bacterial and viral epidemics.

    Trends in the Forecast Period

    Rise in Funding and Government Initiatives

    • More investments in genetic and microbiological research.
    • Enhanced support for healthcare innovation.

    Aging Population

    • Continues to drive demand for multiplex assays.
    • Increased focus on age-related disease detection.

    Increasing Prevalence of Chronic Diseases

    • Chronic diseases are a major health concern.
    • Multiplex assays essential for diagnosis and management.

    Epidemic Outbreaks

    • Rapid rise in bacterial and viral infections.
    • Need for quick and accurate diagnostic tools.

    View More On The Multiplex Assay Market Report 2024 – https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

    Rising Incidence of Chronic Diseases

    Driving Market Growth

    • High incidence of non-communicable diseases (NCDs).
    • WHO reports 41 million deaths annually from NCDs.
    • Multiplex assays preferred for their quick and accurate analysis.

    Advantages Over Traditional Assays

    • Faster analysis times.
    • Greater efficiency in clinical trials.

    Key Players in the Market

    The market features several major companies that are leading innovation and growth:

    • Seegene Inc.
    • DiaSorin SpA
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories Inc.
    • Qiagen NV
    • Abcam PLC
    • PerkinElmer Inc.
    • Hologic Corporation
    • Meso Scale Diagnostics
    • Merck KGaA
    • Roche Diagnostics India Pvt Ltd.

    Notable Acquisition

    • Roche’s Acquisition of GenMark Diagnostics (May 2021)
      • Expanded molecular diagnostics portfolio.
      • Enhanced syndromic testing capabilities.
      • $1.8 billion deal to improve patient care and reduce costs.

    Market Segmentation

    The multiplex assays market is segmented based on type, technology, application, and end-users:

    By Type

    • Protein-Based Multiplex Assays
    • Nucleic Acid-Based Multiplex Assays
    • Other Types

    By Identification Technology

    • Flow Cytometry
    • Multiplex Real-Time PCR
    • Other Identification Technologies

    By Detection Technology

    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Luminescence
    • Fluorescence
    • Other Detection Technologies

    By Application

    • Research and Development
    • Clinical Diagnostics

    By End User

    • Pharmaceutical and Biotechnology Companies
    • Hospitals and Research Institutes
    • Reference Laboratories
    • Other End-Users

    Regional Insights

    • North America was the largest market in 2023.
    • Asia-Pacific is expected to be the fastest-growing region through the forecast period.

    Conclusion

    The multiplex assays market is set for significant growth, driven by increasing healthcare expenditure, technological advances, and a growing aging population. With a projected market size of $5.7 billion by 2028 and major companies leading innovation, the future of multiplex assays looks promising. The market’s evolution will continue to be shaped by rising funding, government initiatives, and the need for efficient diagnostic tools in the face of chronic diseases and epidemics.

    Request A Sample Of The Global Multiplex Assay Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=5775&type=smp